Ex Vivo Induction of Multiple Myeloma-specific Immune Responses by Monocyte-derived Dendritic Cells Following Stimulation by Whole-tumor Antigen of Autologous Myeloma Cells-Reference-Cited by-同舟云学术

Ex Vivo Induction of Multiple Myeloma-specific Immune Responses by Monocyte-derived Dendritic Cells Following Stimulation by Whole-tumor Antigen of Autologous Myeloma Cells

Published:2017-09 Issue:7 Volume:40 Page:253-264
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Vasileiou Spyridoula,Baltadakis Ioannis,Delimpasi Sosanna,Karatza Maria-Helena,Liapis Konstantinos,Garofalaki Maria,Tziotziou Eirini,Poulopoulou Zoe,Karakasis Dimitri,Harhalakis Nicholas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference45 articles.

1. Multiple myeloma: diagnosis and treatment;Rajkumar;Mayo Clin Proc,2016

2. Novel agents in the treatment of multiple myeloma: a review about the future;Naymagon;J Hematol Oncol,2016

3. The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies;Hoyos;Blood,2016

4. Immunobiology of dendritic cells;Banchereau;Annu Rev Immunol,2000

5. Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies;Pyzer;Hum Vaccin Immunother,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic strategies to enhance immune response induced by multiple myeloma cells;Frontiers in Immunology;2023-05-18

2. Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions;International Journal of Molecular Sciences;2022-01-14

3. Immunomodulatory Drugs Alter the Metabolism and the Extracellular Release of Soluble Mediators by Normal Monocytes;Molecules;2020-01-16

4. Immunotherapeutic Strategies for Multiple Myeloma;Cancer Immunology;2020

5. Circulating monocyte subsets in multiple myeloma patients receiving autologous stem cell transplantation – a study of the preconditioning status and the course until posttransplant reconstitution for a consecutive group of patients;BMC Immunology;2019-11-08